Maura N Dickler

Maura N Dickler

UNVERIFIED PROFILE

Are you Maura N Dickler?   Register this Author

Register author
Maura N Dickler

Maura N Dickler

Publications by authors named "Maura N Dickler"

Are you Maura N Dickler?   Register this Author

52Publications

1705Reads

30Profile Views

Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance.

Oncologist 2018 05 19;23(5):528-539. Epub 2018 Jan 19.

Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0423DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947450PMC
May 2018

Checkpoint Inhibitors in the Treatment of Breast Cancer.

Curr Oncol Rep 2018 04 30;20(7):51. Epub 2018 Apr 30.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, 300 E. 66th Street, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0701-2DOI Listing
April 2018

Genetic predisposition to bevacizumab-induced hypertension.

Gynecol Oncol 2017 12 29;147(3):621-625. Epub 2017 Sep 29.

New York University Langone Medical Center, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.09.017DOI Listing
December 2017

Extended Adjuvant Aromatase Inhibitor Therapy in Post-Menopausal Women.

Curr Breast Cancer Rep 2017 Dec 16;9(4):236-241. Epub 2017 Oct 16.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12609-017-0260-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791913PMC
December 2017

Sexual health needs and educational intervention preferences for women with cancer.

Breast Cancer Res Treat 2017 Aug 25;165(1):77-84. Epub 2017 May 25.

Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4305-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515493PMC
August 2017

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.

J Clin Oncol 2016 09 23;34(25):3069-103. Epub 2016 May 23.

Hope S. Rugo, University of California San Francisco Comprehensive Cancer Center; Barbara Fowble, University of California San Francisco, San Francisco; Rita S. Mehta, University of California Irvine, Orange, CA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; James L. Khatcheressian, Virginia Cancer Institute, Richmond, VA; Erin Macrae, Columbus Oncology and Hematology Associates, Columbus, OH; Debra L. Barton, University of Michigan School of Nursing, Ann Arbor, MI; Hannah Klein Connolly, Patient Representative, Edina, MN; Maura N. Dickler, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Lesley Fallowfield, Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Sussex; Stephen R.D. Johnston, Royal Marsden Hospital, London, United Kingdom; James N. Ingle, Mayo Clinic, Rochester, MN; Mohammad Jahanzeb, University of Miami Sylvester Comprehensive Cancer Center, Deerfield Beach, FL; Larissa A. Korde, University of Washington, Seattle, WA; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and Harold J. Burstein, Dana-Farber Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.1487DOI Listing
September 2016

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

J Clin Oncol 2016 08 2;34(22):2602-9. Epub 2016 May 2.

Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.1595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012690PMC
August 2016

Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies.

Endocr Relat Cancer 2016 08 12;23(8):R337-52. Epub 2016 Jul 12.

Memorial Sloan-Kettering Cancer CenterBreast Medicine Service, New York, New York, USA Joan and Sanford I Weill Medical College of Cornell UniversityMedicine, New York, New York, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0121DOI Listing
August 2016

Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?

Breast J 2015 Sep-Oct;21(5):514-9. Epub 2015 Aug 14.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995885PMC
June 2016

Cancer and Fertility Program Improves Patient Satisfaction With Information Received.

J Clin Oncol 2016 05 4;34(15):1780-6. Epub 2016 Apr 4.

Joanne F. Kelvin, Bridgette Thom, Jeanne Carter, Stacie Corcoran, Maura N. Dickler, Matthew J. Matasar, Ariela Noy, and Shari B. Goldfarb, Memorial Sloan Kettering Cancer Center, New York; Catherine Benedict, Hofstra Northwell School of Medicine, Manhasset, NY; Karyn A. Goodman, University of Colorado School of Medicine, Aurora, CO; and Allison Margolies, Newton-Wellesley Hospital, Newton, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966338PMC
May 2016

Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.

Cancer 2016 Apr 9;122(8):1178-84. Epub 2016 Feb 9.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29903DOI Listing
April 2016

Molecular Imaging of Biomarkers in Breast Cancer.

J Nucl Med 2016 Feb;57 Suppl 1:53S-9S

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Department of Radiology, Weill Cornell Medical College, New York, New York; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.157909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979972PMC
February 2016

The Role of CDK4/6 Inhibition in Breast Cancer.

Oncologist 2015 May 15;20(5):483-90. Epub 2015 Apr 15.

Department of Medical Oncology, Bon Secours Hospital, Cork, Ireland; Breast Medicine Service, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425391PMC
May 2015

Alopecia with endocrine therapies in patients with cancer.

Oncologist 2013 13;18(10):1126-34. Epub 2013 Sep 13.

School of Medicine, New York University Langone Medical Center, New York, New York, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805155PMC
May 2014

Endocrine therapy for advanced breast cancer.

Clin Adv Hematol Oncol 2014 Apr;12(4):214-23

Memorial Sloan Kettering Cancer Center, Weill Medical College, Cornell University, New York, New York.

View Article

Download full-text PDF

Source
April 2014

Nonimmediate hypersensitivity reaction after trastuzumab infusion: a suspected drug-virus interaction.

J Clin Oncol 2013 Aug 10;31(24):e407-9. Epub 2013 Jun 10.

Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.9958DOI Listing
August 2013

Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.

Radiology 2012 Sep 6;264(3):670-8. Epub 2012 Jul 6.

Department of Radiology, Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.12112669DOI Listing
September 2012

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.

Breast Cancer Res Treat 2012 Jul 24;134(1):13-20. Epub 2011 Dec 24.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., 2nd Floor, Box 1710, B-608, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1918-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397213PMC
July 2012

Characteristics of oral mucosal events related to bevacizumab treatment.

Oncologist 2012 26;17(2):274-8. Epub 2012 Jan 26.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10022, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286177PMC
June 2012

Bevacizumab in metastatic breast cancer: when may it be used?

Ther Adv Med Oncol 2011 Mar;3(2):85-93

Memorial Sloan-Kettering Cancer Center, Medicine and Epidemiology and Biostatistics, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834010397627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126041PMC
March 2011

Updates on therapeutic approaches in HER2-positive disease.

Authors:
Maura N Dickler

Clin Adv Hematol Oncol 2010 Feb;8(2):105-7

Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
February 2010

Bevacizumab for advanced breast cancer.

Womens Health (Lond) 2010 Jan;6(1):17-25

Breast Cancer Medicine Service, Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/whe.09.71DOI Listing
January 2010

Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.

Breast Cancer Res Treat 2009 May 22;115(1):115-21. Epub 2008 May 22.

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0055-9DOI Listing
May 2009

Aromatase inhibitors and arthralgia: a growing pain?

Oncology (Williston Park) 2008 Nov;22(12):1424, 1426

View Article

Download full-text PDF

Source
November 2008

Biomarkers in breast cancer.

Cancer Biol Ther 2008 Jan 11;7(1):21-2. Epub 2008 Feb 11.

Breast Cancer Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.7.1.5590DOI Listing
January 2008

When you look matters: the effect of assessment schedule on progression-free survival.

J Natl Cancer Inst 2007 Mar;99(6):428-32

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd St, 3rd Fl, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djk091DOI Listing
March 2007

Maximizing the potential of bevacizumab in cancer treatment.

Oncologist 2004 ;9 Suppl 1:36-42

Department of Medicine, University of California, San Francisco, California 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.9-suppl_1-36DOI Listing
April 2006

Small-Fiber Neuropathy Associated with Capecitabine (Xeloda)-induced Hand-foot Syndrome: A Case Report.

J Clin Neuromuscul Dis 2006 Mar;7(3):128-32

*Department of Neurology, Memorial Sloan-Kettering Cancer Center, Rehabilitation Medicine Service daggerDepartment of Neurology, New York-Presbyterian Hospital, Neurological Institute double daggerMemorial Sloan-Kettering Cancer Center, Breast Cancer Medicine Service, New York City, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cnd.0000211401.19995.a2DOI Listing
March 2006

Aromatase inhibitors for hormonal therapy of early-stage breast cancer.

Curr Opin Investig Drugs 2004 Jun;5(6):605-10

Memorial Sloan-Kettering Cancer Center, Department of Medicine, Breast Cancer Medicine Service, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
June 2004